| Abstrakt: |
Purpose: Ectopic Cushing’s syndrome (ECS) caused by an ACTH secreting neuroendocrine neoplasm (NEN) is a rare and challenging condition. We aimed to detect predictive and prognostic parameters for ECS patients identified from a retrospective, comprehensive cohort of NENs treated at a tertiary referral center. Methods: Medical records of 886 patients with NENs were reviewed. We identified 51 patients with ECS (33 females/18 men); mean age 52 ± 15 years (SD). Clinical parameters including symptoms, biochemical markers, and survival were extracted and further analyzed. Results: The primary tumor was located in the thorax (n= 28) or pancreas (n= 15) or was of unknown primary origin (n= 8). In 30 patients, tumor and ECS were diagnosed simultaneously. In 12 patients, the NEN diagnosis preceded ECS development, with a median time of 43.5 months (range: 9–96), and 10 of these showed radiological tumor progression at ECS diagnosis. Twenty-one patients had multiple hormone secretion, which correlated with shorter overall survival (OS), p= 0.012 (HR 2.4 (95% CI 1.2–4.9)), as did high morning cortisol, p= 0.037 (HR 2.3 (1.0–5.2)), higher tumor grade, p= 0.044 (HR 2.3 (1.0–5.1)), and diabetes, p= 0.050 (HR 2.4 (1.0–6.0)). Conclusions: Multiple hormone secretion, high morning cortisol, higher tumor grade, and diabetes were correlated with shorter OS. Development of ECS in patients with a non-functioning NEN may indicate tumor progression. Multiple hormone secretion should be considered as a bad prognostic sign in ECS patients and should lead to intensified clinical management. |
Full text from SpringerLink